462 related articles for article (PubMed ID: 26447542)
21. Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: a single-center retrospective study.
Antonelli A; Arrighi N; Corti S; Zanotelli T; Cozzoli A; Cosciani Cunico S; Simeone C
Urol Oncol; 2013 Oct; 31(7):1310-5. PubMed ID: 22281433
[TBL] [Abstract][Full Text] [Related]
22. European Crohn's and Colitis Organisation Topical Review on IBD in the Elderly.
Sturm A; Maaser C; Mendall M; Karagiannis D; Karatzas P; Ipenburg N; Sebastian S; Rizzello F; Limdi J; Katsanos K; Schmidt C; Jeuring S; Colombo F; Gionchetti P
J Crohns Colitis; 2017 Mar; 11(3):263-273. PubMed ID: 27797918
[TBL] [Abstract][Full Text] [Related]
23. Course of inflammatory bowel disease in patients infected with human immunodeficiency virus.
Viazis N; Vlachogiannakos J; Georgiou O; Rodias M; Georgiadis D; Papastamopoulos V; Baraboutis IG; Karamanolis DG; Skoutelis A
Inflamm Bowel Dis; 2010 Mar; 16(3):507-11. PubMed ID: 19714759
[TBL] [Abstract][Full Text] [Related]
24. Seroprevalence of Epstein-Barr Virus, Cytomegalovirus, and Polyomaviruses in Children with Inflammatory Bowel Disease.
Hradsky O; Copova I; Zarubova K; Durilova M; Nevoral J; Maminak M; Hubacek P; Bronsky J
Dig Dis Sci; 2015 Nov; 60(11):3399-407. PubMed ID: 26091801
[TBL] [Abstract][Full Text] [Related]
25. Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study.
Charpentier C; Salleron J; Savoye G; Fumery M; Merle V; Laberenne JE; Vasseur F; Dupas JL; Cortot A; Dauchet L; Peyrin-Biroulet L; Lerebours E; Colombel JF; Gower-Rousseau C
Gut; 2014 Mar; 63(3):423-32. PubMed ID: 23408350
[TBL] [Abstract][Full Text] [Related]
26. Similar clinical characteristics of familial and sporadic inflammatory bowel disease in South Korea.
Chung SH; Park SJ; Lee HS; Hong SP; Cheon JH; Kim TI; Kim WH
World J Gastroenterol; 2014 Dec; 20(45):17120-6. PubMed ID: 25493025
[TBL] [Abstract][Full Text] [Related]
27. CD1d expression in renal cell carcinoma is associated with higher relapse rates, poorer cancer-specific and overall survival.
Chong TW; Goh FY; Sim MY; Huang HH; Thike AA; Lim WK; Teh BT; Tan PH
J Clin Pathol; 2015 Mar; 68(3):200-5. PubMed ID: 25477528
[TBL] [Abstract][Full Text] [Related]
28. Increased Mortality of Patients With Childhood-Onset Inflammatory Bowel Diseases, Compared With the General Population.
Olén O; Askling J; Sachs MC; Frumento P; Neovius M; Smedby KE; Ekbom A; Malmborg P; Ludvigsson JF
Gastroenterology; 2019 Feb; 156(3):614-622. PubMed ID: 30342031
[TBL] [Abstract][Full Text] [Related]
29. Evolution of the prevalence and characteristics of anemia in inflammatory bowel diseases between 1993 and 2003.
Vijverman A; Piront P; Belaiche J; Louis E
Acta Gastroenterol Belg; 2006; 69(1):1-4. PubMed ID: 16673554
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory bowel disease in an underdeveloped region of Northeastern Brazil.
Parente JM; Coy CS; Campelo V; Parente MP; Costa LA; da Silva RM; Stephan C; Zeitune JM
World J Gastroenterol; 2015 Jan; 21(4):1197-206. PubMed ID: 25632193
[TBL] [Abstract][Full Text] [Related]
31. Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort.
Schnitzler F; Friedrich M; Stallhofer J; Schönermarck U; Fischereder M; Habicht A; Karbalai N; Wolf C; Angelberger M; Olszak T; Beigel F; Tillack C; Göke B; Zachoval R; Denk G; Guba M; Rust C; Grüner N; Brand S
PLoS One; 2015; 10(8):e0135807. PubMed ID: 26288187
[TBL] [Abstract][Full Text] [Related]
32. Risk Factors and Clinical Outcomes in Patients with IBD with Melanoma.
Nissen LHC; Pierik M; Derikx LAAP; de Jong E; Kievit W; van den Heuvel TRA; van Rosendael AR; Plasmeijer EI; Dewint P; Verhoeven RHA; Overbeek LIH; Nagtegaal ID; Hoentjen F; van der Meulen-de Jong AE
Inflamm Bowel Dis; 2017 Nov; 23(11):2018-2026. PubMed ID: 28837522
[TBL] [Abstract][Full Text] [Related]
33. Burden of disease and increasing prevalence of inflammatory bowel disease in a population-based cohort in the Netherlands.
de Groof EJ; Rossen NG; van Rhijn BD; Karregat EP; Boonstra K; Hageman I; Bennebroek Evertsz F; Kingma PJ; Naber AH; van den Brande JH; Mallant-Hent RC; Mundt MW; D'Haens GR; Ponsioen CY
Eur J Gastroenterol Hepatol; 2016 Sep; 28(9):1065-72. PubMed ID: 27281507
[TBL] [Abstract][Full Text] [Related]
34. Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease.
Hyams JS; Dubinsky MC; Baldassano RN; Colletti RB; Cucchiara S; Escher J; Faubion W; Fell J; Gold BD; Griffiths A; Koletzko S; Kugathasan S; Markowitz J; Ruemmele FM; Veereman G; Winter H; Masel N; Shin CR; Tang KL; Thayu M
Gastroenterology; 2017 Jun; 152(8):1901-1914.e3. PubMed ID: 28193515
[TBL] [Abstract][Full Text] [Related]
35. Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease Cohort.
Godat S; Fournier N; Safroneeva E; Juillerat P; Nydegger A; Straumann A; Vavricka S; Biedermann L; Greuter T; Fraga M; Abdelrahman K; Hahnloser D; Sauter B; Rogler G; Michetti P; Schoepfer AM;
Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):612-620. PubMed ID: 29384798
[TBL] [Abstract][Full Text] [Related]
36. Impact of Young Age at Diagnosis on Survival in Patients with Surgically Treated Renal Cell Carcinoma: a Multicenter Study.
Kang HW; Seo SP; Kim WT; Yun SJ; Lee SC; Kim WJ; Hwang EC; Kang SH; Hong SH; Chung J; Kwon TG; Kim HH; Kwak C; Byun SS; Kim YJ;
J Korean Med Sci; 2016 Dec; 31(12):1976-1982. PubMed ID: 27822938
[TBL] [Abstract][Full Text] [Related]
37. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
[TBL] [Abstract][Full Text] [Related]
38. Increased risk of atrial fibrillation and stroke during active stages of inflammatory bowel disease: a nationwide study.
Kristensen SL; Lindhardsen J; Ahlehoff O; Erichsen R; Lamberts M; Khalid U; Torp-Pedersen C; Nielsen OH; Gislason GH; Hansen PR
Europace; 2014 Apr; 16(4):477-84. PubMed ID: 24108228
[TBL] [Abstract][Full Text] [Related]
39. Risk factors of work disability in patients with inflammatory bowel disease--a Dutch nationwide web-based survey: work disability in inflammatory bowel disease.
van der Valk ME; Mangen MJ; Leenders M; Dijkstra G; van Bodegraven AA; Fidder HH; de Jong DJ; Pierik M; van der Woude CJ; Romberg-Camps MJ; Clemens CH; Jansen JM; Mahmmod N; van de Meeberg PC; van der Meulen-de Jong AE; Ponsioen CY; Bolwerk CJ; Vermeijden JR; Siersema PD; van Oijen MG; Oldenburg B; ;
J Crohns Colitis; 2014 Jul; 8(7):590-7. PubMed ID: 24351733
[TBL] [Abstract][Full Text] [Related]
40. Widespread but not localized neoplasia in inflammatory bowel disease worsens the prognosis of colorectal cancer.
Brackmann S; Aamodt G; Andersen SN; Roald B; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Inflamm Bowel Dis; 2010 Mar; 16(3):474-81. PubMed ID: 19714748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]